Moreover, IL-6 has context-dependent roles in obesity and diabetes (Alexaki, 2024; Wueest and Konrad, 2020), suggesting that the IL-6/CERS axis may underlie a shared lipotoxic program when IL-6 drives liver dysregulation in these settings. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.